Both in Pharmaceuticals
Disc Medicine vs Supernus Pharmaceuticals
Over the past year IRON returned +1.2% and SUPN returned −7.6%; their daily moves had a correlation of 0.11.
IRON +1.2% SUPN −7.6%Growth of $1, one year, split-adjusted
| Metric | IRON | SUPN |
|---|---|---|
| Price | $65.87 | $43.97 |
| Market cap | $2.53B | $2.56B |
| Today | +1.46% | −1.41% |
| 1 month | −17.7% | +0.5% |
| 6 months | +8.4% | −10.9% |
| Year to date | −17.1% | −11.5% |
| 1 year | +0.5% | −6.5% |
| Revenue growth (YoY) | — | +32.4% |
| Gross margin | — | 84.6% |
| Net margin | — | −26.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.1× |
| Net cash | $658.4M | $372.1M |
| Dividend yield | — | — |
| Volatility (60d) | 33.9% | 35.9% |
| Short % of float | 21.2% | 9.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).